TuHURA Biosciences (HURA) News Today $4.48 +0.48 (+12.00%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period TuHURA Biosciences (NASDAQ:HURA) Upgraded at RODMAN&RENSHAWDecember 21 at 1:59 AM | americanbankingnews.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTS and HURA on Behalf of ShareholdersDecember 20 at 10:18 AM | globenewswire.comTuHURA Biosciences (NASDAQ:HURA) Rating Increased to Strong-Buy at RODMAN&RENSHAWRODMAN&RENSHAW upgraded shares of TuHURA Biosciences to a "strong-buy" rating in a research note on Thursday.December 20 at 6:05 AM | marketbeat.comRodman & Renshaw Begins Coverage on TuHURA Biosciences (NASDAQ:HURA)Rodman & Renshaw assumed coverage on TuHURA Biosciences in a research note on Thursday. They set a "buy" rating and a $11.00 target price for the company.December 19 at 8:20 AM | marketbeat.comTuHURA Biosciences initiated with a Buy at Rodman & RenshawDecember 18 at 5:11 PM | tipranks.comTuHURA Biosciences Enters Merger Agreement with Kineta, Inc. - Potential Expansion of Immunotherapy PipelineTUHURA Biosciences, Inc. (NASDAQ: HURA) has recently announced its decision to engage in a definitive Merger Agreement with Kineta, Inc. This December 14, 2024 | americanbankingnews.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating TuHURA Biosciences, Inc. MergerDecember 13, 2024 | markets.businessinsider.comTuHURA Biosciences to Acquire Kineta, Inc. in 2025December 13, 2024 | markets.businessinsider.comTuHURA Biosciences enters definitive merger agreement to acquire KinetaDecember 12, 2024 | markets.businessinsider.comKineta Merges with TuHURA to Enhance Cancer TreatmentDecember 12, 2024 | markets.businessinsider.comHURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of TuHURA Biosciences, Inc. Is Fair to ShareholdersDecember 12, 2024 | tmcnet.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of TuHURA Biosciences, Inc. - HURADecember 12, 2024 | prnewswire.comTuHURA Biosciences to acquire KinetaDecember 12, 2024 | seekingalpha.comTuhura Biosciences Inc Share Price (HURA.US)December 7, 2024 | lse.co.ukTuHURA Biosciences Advances in Cancer Immunotherapy InnovationsNovember 25, 2024 | tipranks.comTuHURA Biosciences outlines development pathway for IFx-2.0November 25, 2024 | tipranks.comRep. Laurel M. Lee TuHURA Biosciences (NASDAQ:HURA) StockRepresentative Laurel M. Lee (R-Florida) recently bought shares of TuHURA Biosciences (NASDAQ:HURA). In a filing disclosed on November 21st, the Representative disclosed that they had bought between $100,001 and $250,000 in TuHURA Biosciences stock on October 18th. Representative Laurel M. Lee alsoNovember 24, 2024 | marketbeat.comTuHURA Biosciences Inc (HURA)November 23, 2024 | investing.com Get TuHURA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HURA and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol HURA Media Mentions By Week HURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HURA News Sentiment▼0.820.59▲Average Medical News Sentiment HURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HURA Articles This Week▼75▲HURA Articles Average Week Get TuHURA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EOLS News Today RAPP News Today DNTH News Today AUTL News Today PRTA News Today OCS News Today CGEM News Today TECX News Today TRDA News Today ABUS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HURA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TuHURA Biosciences Please log in to your account or sign up in order to add this asset to your watchlist. Share TuHURA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.